Z16.39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z16.39 became effective on October 1, 2021. This is the American ICD-10-CM version of Z16.39 - other international versions of ICD-10 Z16.39 may differ. Z codes represent reasons for encounters.
Body mass index (BMI) 39.0-39.9, adult. 2016 2017 2018 2019 Billable/Specific Code Adult Dx (15-124 years) POA Exempt. Z68.39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Z68.39 became effective on October 1, 2018.
They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition. code to identify any applicable history of disease code ( Z86.-, Z87.-)
ICD-10 Code for Personal history of malignant neoplasm of thyroid- Z85. 850- Codify by AAPC.
9 – Hypothyroidism, Unspecified.
39.
Acromegaly – Pituitary tumor – Pituitary Adenoma (ICD-10 : E22)
E03. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E03.
29.
Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm. E05. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Graves' disease is an autoimmune disease that leads to a generalized overactivity of the entire thyroid gland (hyperthyroidism). It is the most common cause of hyperthyroidism in the United States. It is named after Robert Graves, an Irish physician, who described this form of hyperthyroidism about 150 years ago.
ICD-10 code E05 for Thyrotoxicosis [hyperthyroidism] is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
2: Benign neoplasm: Pituitary gland.
Malignant neoplasm of pituitary gland C75. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C75. 1 became effective on October 1, 2021.
Adenomas are generally benign or non cancerous but carry the potential to become adenocarcinomas which are malignant or cancerous. As benign growths they can grow in size to press upon the surrounding vital structures and leading to severe consequences.
Z86.39 is a valid billable ICD-10 diagnosis code for Personal history of other endocrine, nutritional and metabolic disease . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also: History.